Simon L. Croft, BSc PGCE PhD FRSB
Prof. Simon L. Croft
Simon Croft is Professor of Parasitology in the Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM). He has worked on the discovery and development of anti-infective drugs in academia, industry and public-private partnerships. Simon’s research has focussed on novel drugs and formulations for the treatment of leishmaniasis, malaria, human African trypanosomiasis and Chagas disease, including projects on miltefosine, AmBisome and topical paromomycin which reached clinical trials for the treatment of leishmaniasis. Current research interests include PK PD relationships, topical formulations, predictive models for drugs and vaccines and leishmaniasis control programmes (KalaCORE and SPEAK India). He works extensively with industry and Product Development Partnership (PDPs) on neglected tropical diseases and a network of collaborators in disease endemic countries. From 2004 to 2007 Simon was the R&D Director of the Drugs for Neglected Diseases Initiative (DNDi), Geneva and from 2008 to 2014 he was Dean of Faculty at the LSHTM.
Prof. Nirmal Kumar Ganguly
Prof. Nirmal K. Ganguly
Prof. Nirmal Kumar Ganguly, M.D. is the former Director General, Indian Council of Medical Research (ICMR) and also was formerly a Distinguished Biotechnology Research Professor, Department of Biotechnology, Government of India. Prof. Ganguly has more than 40 years of research and training experience. His major areas of research have been Tropical Diseases, Cardiovascular Diseases and Diarrheal Diseases. His interest encompasses the disciplines of Immunology, Biotechnology and Public Health. Prof. N. K. Ganguly has contributed immensely to Leishmania research and its eradication programmes. As Director General – Indian Council of Medical Research, Prof. Ganguly has initiated several research programmes and clinical trials on new drug combinations for Leishmaniasis. His research has deciphered pathways for mode of infection, immune response and drug efficacy. He has several scientific publications to his credit on Visceral Leishmaniasis. Over the years he has been an active member of several WHO Committees for control, management and eradication of Visceral Leishmaniais.
Prof. David Smith, B.Phil., B.D., S.T.L., M.A., S.T.D
Prof. David Smith
David Smith is Associate Professor of Health Care Ethics in Royal College of Surgeons in Ireland (RCSI) and Director of the MSc in Health Care Ethics and Law. He is a member of the following Research Ethics Committees in Ireland: Chairperson the Human Research Ethics Committee in RCSI; Chairperson of the Animal Research Ethics Committee in RCSI; Member of the Rotunda Research Ethics Committee; Member of the Research Ethics Committee Beaumont University Hospital, Dublin; Member of the Faculty Research Ethics Committee – Faculty of Health Science – Trinity College; Member of the Daughters of Charity Services Research Ethics Committee; Chairperson of the Bon Secours Health System Research Ethics Committee; Members of the Research Ethics Committee of the Faculty of Public Health. He is also ethics consultant to following HP7 and H2020 projects:
H2020 PREV_PKDL; H2020 PurinexDX; H2020 Programme TRANSVAC2; H2020 Gliotrain; H2020 Watersproutt; H2020 Programme ZIKAVAX; H2020 Programme SURG-Africa; H2020 Programme DRIVE; H2020 COST Action IS1303; FP7-funded programme EPIMIRNA; FP7 entitled Hypotension in Prems HIP